The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells

被引:31
作者
Shehu-Xhilaga, Miranda [1 ,2 ]
Rhodes, David [3 ]
Wightman, Fiona [1 ,2 ]
Liu, Hong B. [4 ]
Solomon, Ajantha [1 ,2 ]
Saleh, Suha [1 ,2 ]
Dear, Anthony E. [4 ]
Cameron, Paul U. [1 ,2 ]
Lewin, Sharon R. [1 ,2 ,5 ]
机构
[1] Alfred Hosp, Infect Dis Unit, Sydney, NSW, Australia
[2] Monash Univ, Dept Med, Clayton, Vic 3800, Australia
[3] Avexa Ltd, Richmond, VA USA
[4] Monash Univ, Australian Ctr Blood Dis, Clayton, Vic 3800, Australia
[5] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
SUBEROYLANILIDE HYDROXAMIC ACID; CD4(+) T-CELLS; VALPROIC ACID; CANCER CELLS; IN-VITRO; EXPRESSION; RESERVOIR; RECRUITMENT; OXAMFLATIN; STABILITY;
D O I
10.1097/QAD.0b013e328330342c
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the ability of several novel class I histone deacetylase inhibitors to activate HIV-1 transcription in latently infected cell lines. Oxamflatin, metacept-1 and metacept-3 induced high levels of HIV-1 transcription in latently infected T cell and monocytic cells lines, were potent inhibitors of histone deacetylase activity and caused preferential cell death in transcriptionally active cells. Although these compounds had potent in-vitro activity, their cytotoxicity may limit their use in patients.
引用
收藏
页码:2047 / 2050
页数:4
相关论文
共 29 条
[1]   Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid [J].
Archin, Nancie M. ;
Espeseth, Amy ;
Parker, Daniel ;
Cheema, Manzoor ;
Hazuda, Daria ;
Margolis, David M. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) :207-212
[2]   Valproic acid (VPA) in patients with refractory advanced cancer:: a dose escalating phase I clinical trial [J].
Atmaca, A. ;
Al-Batran, S-E ;
Maurer, A. ;
Neumann, A. ;
Heinzel, T. ;
Hentsch, B. ;
Schwarz, S. E. ;
Hovelmann, S. ;
Goettlicher, M. ;
Knuth, A. ;
Jaeger, E. .
BRITISH JOURNAL OF CANCER, 2007, 97 (02) :177-182
[3]  
CLOUSE KA, 1989, J IMMUNOL, V143, P470
[4]   Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells [J].
Contreras, Xavier ;
Schweneker, Marc ;
Chen, Ching-Shih ;
McCune, Joseph M. ;
Deeks, Steven G. ;
Martin, Jeffrey ;
Peterlin, B. Matija .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (11) :6782-6789
[5]   Conformational analogues of Oxamflatin as histone deacetylase inhibitors [J].
Dear, Anthony E. ;
Liu, Hong B. ;
Mayes, Penelope A. ;
Perlmutter, Patrick .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (20) :3778-3784
[6]   Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency [J].
Duverger, Alexandra ;
Jones, Jennifer ;
May, Jori ;
Bibollet-Ruche, Frederic ;
Wagner, Frederic A. ;
Cron, Randall Q. ;
Kutsch, Olaf .
JOURNAL OF VIROLOGY, 2009, 83 (07) :3078-3093
[7]   Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].
Finzi, D ;
Hermankova, M ;
Pierson, T ;
Carruth, LM ;
Buck, C ;
Chaisson, RE ;
Quinn, TC ;
Chadwick, K ;
Margolick, J ;
Brookmeyer, R ;
Gallant, J ;
Markowitz, M ;
Ho, DD ;
Richman, DD ;
Siliciano, RF .
SCIENCE, 1997, 278 (5341) :1295-1300
[8]   A new reporter cell line to monitor HIV infection and drug susceptibility in vitro [J].
Gervaix, A ;
West, D ;
Leoni, LM ;
Richman, DD ;
WongStaal, F ;
Corbeil, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4653-4658
[9]   HIV reproducibly establishes a latent infection after acute infection of T cells in vitro [J].
Jordan, A ;
Bisgrove, D ;
Verdin, E .
EMBO JOURNAL, 2003, 22 (08) :1868-1877
[10]   Histone deacetylase complexes: functional entities or molecular reservoirs [J].
Khochbin, S ;
Kao, HY .
FEBS LETTERS, 2001, 494 (03) :141-144